公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2019 | Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials | Cahn P.; Madero J.S.; Arribas J.R.; Antinori A.; Ortiz R.; Clarke A.E.; CHIEN-CHING HUNG ; Rockstroh J.K.; Girard P.-M.; Sievers J.; Man C.; Currie A.; Underwood M.; Tenorio A.R.; Pappa K.; Wynne B.; Fettiplace A.; Gartland M.; Aboud M.; Smith K.; Cassetti L.; David D.; Figueras L.; Losso M.; Lopardo G.; Lupo S.; Porteiro N.; Sánchez M.; Bloch M.; Cooper D.; Finlayson R.; Kelleher A.; Koh K.; Lewis D.; McMahon J.; Moore R.; Roth N.; Shields M.; De Wit S.; Florence E.; Goffard J.-C.; Demeester R.; Lacor P.; Vandercam B.; Vandekerckhove L.; Angel J.; Baril J.-G.; Conway B.; De Pokomandy A.; Szabo J.; Walmsley S.; Bouchaud O.; Chidiac C.; Delobel P.; Goujard C.; Katlama C.; Molina J.-M.; Pialoux G.; Philibert P.; Bogner J.; Esser S.; Krznaric I.; Lehmann C.; Spinner C.; Stellbrink H.-J.; Stephan C.; Stoehr A.; Barchi E.; Caramello P.; Castelli F.; Cattelan A.M.; D'Arminio Monforte A.; Di Biagio A.; Di Perri G.; Gori A.; Maggiolo F.; Menzaghi B.; Migliorino G.; Mussini C.; Penco G.; Puoti M.; Rizzardini G.; Gulminetti R.; Lazzarin A.; Quirino T.; Sighinolfi L.; Viale P.; Amaya Tapia G.; Andrade Villanueva J.; Granados Reyes E.R.; Perez Rios A.; Santoscoy Gomez M.; Den Hollander J.; Rijnders B.; Hidalgo J.A.; Hercilla Vasquez L.; Illescas L.; Olczak A.; Mansinho K.; Correia Pacheco P.P.; Teófilo E.; Saraiva da Cunha J.; Sarmento e Castro R.; Serrão R.; Arbune M.; Jianu C.; Oprea A.; Preotescu L.; Prisacariu L.-J.; Belonosova E.; Borodkina O.; Chernova O.; Gankina N.; Kizhlo S.; Kulagin V.; Kurina N.; Nagimova F.; Pokrovsky V.; Ryamova E.; Voronin E.; Yakovlev A.; Kaplan R.; Lee S.H.; Kim S.-W.; Kim S.-I.; Kim W.J.; Antela Lopez A.; Casado Osorio J.L.; Castaño Carracedo M.A.; De Los Santos Gil I.; Estrada Perez V.; Falco Ferrer V.; Force L.; Galinda Puerto M.J.; Garcia Deltoro M.; Gatell J.M.; Goenaga Sanchez M.A.; González Cordón A.; Knobel H.; Lopez Bernaldo de Quiros J.C.; Losa Garcia J.E.; Masia M.; Montero-Alsonso M.; Ocampo Hermida A.; Pasquau Liaño J.; Portilla Sogorb J.; Pulido Ortega F.; Rivera Roman A.; Santos Fernandez J.R.; Torres Perea R.; Troya Garcia J.; Viciana Fernandez P.; Calmy A.; Hauser C.; Fehr J.; Cheng S.-H.; Ko W.-C.; Lin H.-H.; Lu P.-L.; Tseng Y.-T.; Wang N.-C.; Wong W.-W.; Yang C.-J.; Arduino R.; Benson P.; Berhe M.; Bredeek F.; Brinson C.; Campbell T.; Crofoot G.; Cunningham D.; DeJesus E.; Dretler R.; Eron J.; Fife K.; Fichtenbaum C.; Flamm J.; Goldstein D.; Gupta S.; Hagins D.; Hoffman-Terry M.; Jayaweera D.; Kinder C.; Klein D.; McDonald C.; Mills A.; Nahass R.; Osiyemi O.; Overton E.; Parks D.; Prelutsky D.; Ramgopal M.; Schrader S.; Sha B.; Simon G.; Sims J.; Skiest D.; Slim J.; Tashima K.; Thedinger B.; Gazzard B.; Fox J.; Johnson M.; Kegg S.; Khoo S.; Mazhude C.; Orkin C.; Schembri G.; Ustianowski A.; GEMINI Study Team | The Lancet | 252 | 238 | |
2021 | Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV | Lee Y.-L.; KUAN-YIN LIN ; Cheng S.-H.; Lu P.-L.; Wang N.-C.; Ho M.-W.; Yang C.-J.; Liou B.-H.; Tang H.-J.; Huang S.-S.; Huang S.-H.; Chen T.-C.; Lin C.-Y.; Lin S.-P.; Lee Y.-T.; CHIEN-CHING HUNG ; Taiwan HIV Study Group | International Journal of Antimicrobial Agents | 2 | 0 | |
2019 | Early Seroreversion After 2 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus–Positive Patients: Incidence and Associated Factors | Huang S.-H.; Huang C.-H.; Wang N.-C.; Chen T.-C.; Lee Y.-T.; Lin S.-P.; Lin T.-Y.; Lin C.-Y.; Lee Y.-L.; Lee C.-H.; Chen C.-P.; KUAN-YIN LIN ; Chen G.-J.; Liu C.-E.; Cheng S.-H.; Lu P.-L.; Yang C.-J.; CHIEN-CHING HUNG ; on behalf of the Taiwan HIV Study Group | Hepatology | 17 | 15 | |
2019 | Echinocandins as alternative treatment for HIV-infected patients with Pneumocystis pneumonia | YU-SHAN HUANG ; Liu C.-E.; Lin S.-P.; Lee C.-H.; Yang C.-J.; Lin C.-Y.; Tang H.-J.; Lee Y.-C.; Lin Y.-C.; Lee Y.-T.; HSIN-YUN SUN ; CHIEN-CHING HUNG | AIDS | 19 | 13 | |
2018 | Effect of extracorporeal membrane oxygenation on the new vancomycin dosing regimen in critically Ill patients receiving continuous venovenous hemofiltration | Yang C.-J.; Wu C.-W.; CHIEN-CHIH WU | Therapeutic Drug Monitoring | 7 | 8 | |
2022 | Effectiveness of hepatitis A vaccination among people living with HIV in Taiwan: Is one dose enough? | Tsai P.-H.; Tsai M.-S.; Chiang Y.-H.; Shih C.-Y.; Liu C.-Y.; YU-CHUNG CHUANG ; Yang C.-J. | Journal of Microbiology, Immunology and Infection | 1 | 3 | |
2021 | Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients | YU-SHAN HUANG ; Cheng C.-Y.; Liou B.-H.; Lu P.-L.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; HSIN-YUN SUN ; Yang C.-J.; Tang H.-J.; Lin S.-P.; Ho M.-W.; Huang S.-H.; Tsai H.-C.; Lee C.-H.; CHIEN-CHING HUNG ; Taiwan HIV Study Group | Journal of acquired immune deficiency syndromes (1999) | 10 | 9 | |
2012 | Evaluation of macrolide resistance and enhanced molecular typing of Treponema pallidum in patients with syphilis in taiwan: A prospective multicenter study | Wu H.; SUI-YUAN CHANG ; Lee N.-Y.; Huang W.-C.; Wu B.-R.; Yang C.-J.; Liang S.-H.; Lee C.-H.; Ko W.-C.; Lin H.-H.; Chen Y.-H.; Liu W.-C.; Su Y.-C.; Hsieh C.-Y.; Wu P.-Y.; CHIEN-CHING HUNG | Journal of Clinical Microbiology | 41 | 35 | |
2017 | Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan | Lee Y.-L.; KUAN-YIN LIN ; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; YU-SHAN HUANG ; HSIN-YUN SUN ; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; CHIEN-CHING HUNG ; Taiwan HIV Study Group | PLoS ONE | 15 | 11 | |
2015 | Excess Mortality Associated with Colistin-Tigecycline Compared with Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia: A Multicenter Prospective Observational Study | ARISTINE CHENG ; YU-CHUNG CHUANG ; HSIN-YUN SUN ; WANG-HUEI SHENG ; Yang C.-J.; Liao C.-H.; PO-REN HSUEH ; Yang J.-L.; Shen N.-J.; JANN-TAY WANG ; CHIEN-CHING HUNG ; YEE-CHUN CHEN ; SHAN-CHWEN CHANG | Critical Care Medicine | 105 | 90 | |
2021 | First-line anaplastic lymphoma kinase (Alk) inhibitors for alk-positive lung cancer in asian populations: Systematic review and network meta-analysis | Wu K.-L.; Chen H.-L.; Tsai Y.-M.; Lee T.-H.; Chang H.-M.; Tsai Y.-C.; Chuang C.-H.; Chang Y.-C.; YU-KANG TU ; Yang C.-J.; Hung J.-Y.; Chong I.-W. | Journal of Clinical Medicine | 8 | 6 | |
2018 | Flora of nam kading national protected area III: Begonia namkadingensis (Begoniaceae), a new species in limestone area | Yang C.-J.; Tagane S.; Souladeth P.; Okabe N.; Hu J.-M.; Yahara T.; JER-MING HU | Phytotaxa | 18 | 12 | |
2013 | Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer | Chen C.-Y.; Jan Y.-H.; Juan Y.-H.; Yang C.-J.; Huang M.-S.; CHONG-JEN YU ; PAN-CHYR YANG ; Hsiao M.; Hsu T.-L.; Wong C.-H. | Proceedings of the National Academy of Sciences of the United States of America | 210 | 189 | |
2010 | H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM | Chen M.-W.; KUO-TAI HUA ; Kao H.-J.; Chi C.-C.; LING-HUNG WEI ; Johansson G.; Shiah S.-G.; Chen P.-S.; YUNG-MING JENG ; TSU-YAO CHENG ; Lai T.-C.; Chang J.-S.; Jan Y.-H.; Chien M.-H.; Yang C.-J.; Huang M.-S.; Hsiao M.; Kuo M.-L. | Cancer Research | 300 | 279 | |
2011 | In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to nemonoxacin, tigecycline, fosfomycin and other antimicrobial agents | Hsu M.-S.; Liao C.-H.; Liu C.-Y.; Yang C.-J.; YU-TSUNG HUANG ; PO-REN HSUEH | International Journal of Antimicrobial Agents | 26 | 21 | |
2014 | Incidence and risk factors of skin rashes and hepatotoxicity in HIV-infected patients receiving nevirapine-containing combination antiretroviral therapy in Taiwan | Tseng Y.-T.; Yang C.-J.; SUI-YUAN CHANG ; SHU-WEN LIN ; Tsai M.-S.; Liu W.-C.; Wu P.-Y.; Su Y.-C.; Luo Y.-Z.; Yang S.-P.; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG | International Journal of Infectious Diseases | 12 | 10 | |
2012 | Incidence of acute pancreatitis in human immunodeficiency virus-positive patients with hypertriglyceridemia: Is it really high? | HSIN-YUN SUN ; SUI-YUAN CHANG ; WANG-HUEI SHENG ; Chen M.-Y.; SZU-MIN HSIEH ; Tseng Y.-T.; Lu C.-L.; Yang C.-J.; Wu H.; Liu W.-C.; Wu C.-H.; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG | Pancreas | 5 | 5 | |
2010 | Jarisch-Herxheimer reaction after penicillin therapy among patients with syphilis in the era of the HIV infection epidemic: Incidence and risk factors | Yang C.-J.; Lee N.-Y.; Lin Y.-H.; Lee H.-C.; Ko W.-C.; Liao C.-H.; Wu C.-H.; Hsieh C.-Y.; Wu P.-Y.; Liu W.-C.; Chang Y.-C.; CHIEN-CHING HUNG | Clinical Infectious Diseases | 59 | 55 | |
2014 | Jarisch-Herxheimer reaction among HIV-positive patients with early syphilis: Azithromycin versus benzathine penicillin G therapy | Tsai M.-S.; Yang C.-J.; Lee N.-Y.; SZU-MIN HSIEH ; Lin Y.-H.; HSIN-YUN SUN ; WANG-HUEI SHENG ; Lee K.-Y.; Yang S.-P.; Liu W.-C.; Wu P.-Y.; Ko W.-C.; CHIEN-CHING HUNG | Journal of the International AIDS Society | 25 | 20 | |
2018 | Less severe but prolonged course of acute hepatitis a in Human Immunodeficiency Virus (HIV)-infected patients compared with HIV-uninfected patients during an outbreak: A multicenter observational study | Lee Y.-L.; Chen G.-J.; Chen N.-Y.; Liou B.-H.; Wang N.-C.; Lee Y.-T.; Yang C.-J.; YU-SHAN HUANG ; Tang H.-J.; Huang S.-S.; Lin Y.-C.; Cheng C.-Y.; Lee C.-H.; Chen T.-C.; Wu T.-S.; Liu C.-E.; Lu P.-L.; CHIEN-CHING HUNG ; Lee Y.-C.; Cheng C.-Y.; Cheng S.-H.; Lee Y.-T.; Lin C.-C.; Lin S.-P.; Hsieh C.-Y.; Wang H.-W.; Ho M.-W.; Liu C.-E.; Lee Y.-L.; Lee Y.-C.; Tang H.-J.; Ku H.-C.; Li C.-W.; Lee N.-Y.; Ko W.-C.; Lu P.-L.; Chen Y.-H.; Lin H.-H.; Huang W.-C.; Lee C.-H.; Che T.-C. | Clinical Infectious Diseases | 20 | 18 |